Eli Lilly extends Purdue alliance; EMA investigates Valneva shot

The big pharma will spend up to $250 million over the next eight years of the collaboration. Elsewhere, CRISPR Therapeutics unveiled new data and Vivo Capital raised funds.

FDA layoffs could slow safety communications, experts warn

The mass cuts, which included communications staff, could slow public notices on medical device recalls and other safety alerts.

Speed, flexibility, and efficiency with Demand-led supply (DLS)

Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues.

CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might push for higher standards in the review of medicines under his division's purview.

Biotech startups are built on venture capital. Track funding rounds here.

Sirius Therapeutics raised nearly $50 million in a Series B2 round that will fund clinical testing of RNA medicines for cardiometabolic disease.

Biotech IPOs are the industry’s lifeblood. Track how they’re performing.

Apimeds Pharmaceuticals raised $13.5 million in the year’s smallest biotech IPO to date and the first new stock offering in nearly three months.